Cristcot's Phase 3 Trial Shows Promise for Hydrocortisone Acetate Suppository in Ulcerative Colitis Treatment Cristcot has achieved encouraging results in its Phase 3 trial for a hydrocortisone acetate suppository designed to treat ulcerative colitis, showing potential for rapid symptom relief.

Cristcot's Phase 3 Trial Shows Promise for Hydrocortisone Acetate Suppository in Ulcerative Colitis Treatment #United_States #Hydrocortisone #Cristcot #Sephure #Concord,_Massachusetts